VanEck Biotech ETF · $525M$13,077
BBHBBH vsXBIXBIState Street SPDR S&P Biotech ETF · $10.5B$12,576
$10,000 five years ago, dividends reinvested · they hold 21.1% in common
BBHMeasureXBI
Returns · dividends reinvested
+35.0%Year to dateJan 1 → Nov 3+27.2%
+41.8%1 yearTotal return+38.1%
+21.8%3 years · per year$10,000 became $18,067 · $24,320+34.5%
+5.5%5 years · per year$10,000 became $13,077 · $12,576+4.7%
Cost and income
0.35%Expense ratio$35 · $35 a year on $10k · lower is better0.35%
0.37%Trailing 12-mo yield$37 · $35 a year on $10k0.35%
Risk · past year
−10.5%Worst dropSmaller is better−14.9%
22.3%VolatilityLower is calmer29.1%
BBHXBI Winner of the row, in its colourEach row: the bigger of the two fills its side
6–1BBH wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns